| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/24/2002 | US20020009733 Methods and compositions for modulating melting temperatures of nucleic acids |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009722 Stabilizing agents for preventing the degradation of nucleotide sequences during analysis |
| 01/24/2002 | US20020009721 Methods and formulations for the separation of biological macromolecul |
| 01/24/2002 | US20020009717 Methods for detecting, selecting and cloning agents that degrade or promote degradation of DNA |
| 01/24/2002 | US20020009716 Involves use of rolling circle amplification (RCA) coupled with primer extension and exonuclease deficient polymerases to detect single nucleotide polymorphism (STP); diagnosing genetic disorders |
| 01/24/2002 | US20020009715 Detecting nucleotide sequences which code cell surface protease; incubate target cells with viral display packages and detect signal from transformed cells |
| 01/24/2002 | US20020009708 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/24/2002 | US20020009704 Preparing oocyte for cryogenic suspension; suspend sample in freeze resistant nutrient, rinse, drop onto solid solid surface with good heat conductivity |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
| 01/24/2002 | US20020009435 Polypeptides having haloperoxidase activity |
| 01/24/2002 | US20020009434 Polypeptides having haloperoxidase activity |
| 01/24/2002 | US20020009430 Isolation of tumor cells; incubation |
| 01/24/2002 | US20020009417 Nucleosome-based anti-tumor compositions |
| 01/24/2002 | US20020008053 System and method for manipulating magnetic particles in fluid samples to collect DNA or RNA from a sample |
| 01/24/2002 | US20020007731 Apparatus and method for the remediation of particulate material and toxic pollutants in transit in flue gas |
| 01/24/2002 | DE10126344A1 Apoptose-induzierende DNA-Sequenzen Apoptosis-inducing DNA sequences |
| 01/24/2002 | DE10033991A1 Verfahren zur Isolierung von Nukleinsäuren A process for the isolation of nucleic acids |
| 01/24/2002 | DE10033583A1 Superparamagnetische Perlpolymerisate Superparamagnetic bead polymers |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/24/2002 | DE10033194A1 Biosonden und deren Verwendung Bioprobes and their use |
| 01/24/2002 | DE10032709A1 Aspartyl-Protease Aspartyl protease |
| 01/24/2002 | DE10032608A1 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte For microsatellite instability (MSI +) - related tumors genes and their gene |
| 01/24/2002 | DE10032350A1 New coryneform bacterium in which the mdhA gene is attenuated, preferably eliminated, useful for fermentative production of L-amino acids such as L-lysine |
| 01/24/2002 | DE10032254A1 Nukleotidsequenz kodierend für eine Benzaldehyd-Lyase und Verfahren zur stereoselektiven Synthese von 2-Hydroxyketonen Nucleotide sequence encoding a benzaldehyde lyase and methods for the stereoselective synthesis of 2-hydroxyketones |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | DE10021267A1 Verfahren zur Herstellung modularer Enzymsysteme durch Synthese ihrer Gene in zyklisch wiederholbaren Syntheseschritten A process for producing modular enzyme systems by synthesis of their genes in cyclically repeatable synthesis steps |
| 01/24/2002 | CA2697031A1 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2418155A1 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 01/24/2002 | CA2416986A1 Crf2 ligands in combination therapy |
| 01/24/2002 | CA2416744A1 Device and methods for subdividing and filtering gel material and extracting molecules therefrom |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416559A1 Obesity associated biallelic marker maps |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416222A1 Electrofusion chamber |
| 01/24/2002 | CA2416179A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | CA2416153A1 Mutant rad51 paralog genes and use thereof in anticancer therapy |
| 01/24/2002 | CA2416091A1 Single primer pcr amplification of rna |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415731A1 A method for direct genetic analysis of target cells by using flourescence probes |
| 01/24/2002 | CA2415726A1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | CA2415723A1 Methylated nucleotide regulation of upa gene expression |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415554A1 Method for influencing the content of sinapine in transgenic plant cells and plants |
| 01/24/2002 | CA2415481A1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415344A1 Protease specific cleavable luciferases and methods of use thereof |
| 01/24/2002 | CA2415328A1 Nested sorting and high throughput screening |
| 01/24/2002 | CA2415327A1 Zmaxig1 polynucleotides and methods of use |
| 01/24/2002 | CA2415232A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | CA2415202A1 Extracellular matrix protein |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174522A2 TCF-1 nucleotide sequence variation |
| 01/23/2002 | EP1174521A2 Method for detecting transcribed genomic DNA sequences |
| 01/23/2002 | EP1174517A2 Use of Very Long Chain Fatty Acid Elongase for the identification of herbicides |
| 01/23/2002 | EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
| 01/23/2002 | EP1174513A2 A method for obtaining a genetically modified plant |
| 01/23/2002 | EP1174512A1 Seed composition and method for reducing or preventing the release of genetically manipulated pollen |
| 01/23/2002 | EP1174511A1 Promoters |
| 01/23/2002 | EP1174510A2 Plastidial phosphoglucomutase genes |
| 01/23/2002 | EP1174509A1 Novel cytidine deaminase |
| 01/23/2002 | EP1174508A2 Bacterium producing L-glutamic acid and method for producing L-glutamic acid |
| 01/23/2002 | EP1174507A1 The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174504A1 Apoptosis-associated gene |
| 01/23/2002 | EP1174503A1 Novel proteins, gene encoding the same and method of utilization thereof |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174501A1 Gene expression base sequences for therapeutic use and drugs for gene therapy |
| 01/23/2002 | EP1174499A1 Novel amidase gene |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173766A1 A tenascin-c isoform as a marker for neoplasias |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/23/2002 | EP1173760A1 Encoding of microcarriers |
| 01/23/2002 | EP1173623A1 Solid medium and process for the storage and rapid purification of nucleic acid |
| 01/23/2002 | EP1173622A2 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 01/23/2002 | EP1173620A1 Biochip and method for making same |
| 01/23/2002 | EP1173619A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 01/23/2002 | EP1173614A1 Antisense oligonucleotides comprising universal and/or degenerate bases |
| 01/23/2002 | EP1173613A2 Methods of detecting microorganism using immobilized probes |
| 01/23/2002 | EP1173611A1 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
| 01/23/2002 | EP1173609A2 Genetic analysis |
| 01/23/2002 | EP1173598A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173596A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 01/23/2002 | EP1173595A1 Use of coxsackie viruses for improving cell transfection |
| 01/23/2002 | EP1173594A2 Methods for delivering inhibitory rna to plants and applications thereof |
| 01/23/2002 | EP1173593A2 Gcn4-derived expression of heterologous coding sequences and different uses thereof |
| 01/23/2002 | EP1173592A1 Microbial protein expression system |